AVIR
Atea Pharmaceuticals Inc
NASDAQ: AVIR · HEALTHCARE · BIOTECHNOLOGY
$5.51
+1.47% today
Updated 2026-04-30
Market cap
$435.81M
P/E ratio
—
P/S ratio
1.55x
EPS (TTM)
$-1.94
Dividend yield
—
52W range
$2 – $6
Volume
0.5M
Atea Pharmaceuticals Inc (AVIR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $34.86M | $22.07M | $863.63M | $772.89M | $666.71M | $594.97M | $464.67M |
| Cash & equivalents | $34.49M | $21.66M | $850.12M | $764.38M | $646.71M | $143.82M | $64.70M |
| Current assets | $34.70M | $21.91M | $863.48M | $772.40M | $660.92M | $590.46M | $462.36M |
| Total liabilities | $71.02M | $71.64M | $315.83M | $62.81M | $26.14M | $39.78M | $25.80M |
| Current liabilities | $1.76M | $2.44M | $315.80M | $56.88M | $18.48M | $32.38M | $18.60M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $-36.16M | $-49.57M | $547.80M | $710.08M | $640.57M | $555.19M | $438.87M |
| Retained earnings | $-40.18M | $-54.21M | $-65.16M | $56.03M | $-59.88M | $-195.84M | $-364.22M |
| Accounts receivable | — | — | $5.82M | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |